The Lung Nodule Program brings together a multidisciplinary team of specialists that includes:
The Interventional Pulmonologists are highly trained in advanced procedures and perform electromagnetic navigation, EBUS, EUS, biopsies, as well as, EUS guided left adrenal gland biopsies. These advanced procedures provide patients with a one-step diagnostic biopsy and staging in lung cancer. In addition, cancer compilations are managed by tumor coring, airway stenting, airway dilatation and pleural procedures.
The multidisciplinary approach provides patients with optimal diagnosis and management of lung cancer at all stages. The multidisciplinary team meets often to diagnose, assess, and design targeted customized treatment plans based on the specific characteristics of each patient’s cancer type. Treatment plans may include surgery, CyberKnife, radiation and/or chemotherapy and targeted immunotherapy.
We routinely test lung cancer using a comprehensive tumor gene mutation panel, including several important genes (including EGFR, KRAS, ALK, HER2, and BRAF), in order to select the best possible treatment strategy. The multidisciplinary team and the UCSF Clinical Research Team determine if patients are eligible for clinical trials
. Many of these clinical treatment trials include promising new cancer therapy drugs, targeted therapies, and new drug combinations, with the hope of overcoming drug resistance and improve survival in lung cancer.
Importantly, as a patient or family member, you will also have access to a Clinical Navigator and our entire